93 related articles for article (PubMed ID: 20603643)
21. Proteasome inhibition suppresses DNA-dependent protein kinase activation caused by camptothecin.
Sakasai R; Teraoka H; Tibbetts RS
DNA Repair (Amst); 2010 Jan; 9(1):76-82. PubMed ID: 19959400
[TBL] [Abstract][Full Text] [Related]
22. Gli1 protein regulates the S-phase checkpoint in tumor cells via Bid protein, and its inhibition sensitizes to DNA topoisomerase 1 inhibitors.
Tripathi K; Mani C; Barnett R; Nalluri S; Bachaboina L; Rocconi RP; Athar M; Owen LB; Palle K
J Biol Chem; 2014 Nov; 289(45):31513-25. PubMed ID: 25253693
[TBL] [Abstract][Full Text] [Related]
23. Tipin functions in the protection against topoisomerase I inhibitor.
Hosono Y; Abe T; Higuchi M; Kajii K; Sakuraba S; Tada S; Enomoto T; Seki M
J Biol Chem; 2014 Apr; 289(16):11374-11384. PubMed ID: 24573676
[TBL] [Abstract][Full Text] [Related]
24. Hereditary ataxia SCAN1 cells are defective for the repair of transcription-dependent topoisomerase I cleavage complexes.
Miao ZH; Agama K; Sordet O; Povirk L; Kohn KW; Pommier Y
DNA Repair (Amst); 2006 Dec; 5(12):1489-94. PubMed ID: 16935573
[TBL] [Abstract][Full Text] [Related]
25. Poly(ADP-ribose) polymers regulate DNA topoisomerase I (Top1) nuclear dynamics and camptothecin sensitivity in living cells.
Das SK; Rehman I; Ghosh A; Sengupta S; Majumdar P; Jana B; Das BB
Nucleic Acids Res; 2016 Sep; 44(17):8363-75. PubMed ID: 27466387
[TBL] [Abstract][Full Text] [Related]
26. Analysis of common gene expression patterns in four human tumor cell lines exposed to camptothecin using cDNA microarray: identification of topoisomerase-mediated DNA damage response pathways.
Guo X; Zhang J; Fu X; Wei Q; Lu Y; Li Y; Yin G; Mao Y; Xie Y; Rui Y; Ying K
Front Biosci; 2006 May; 11():1924-31. PubMed ID: 16368568
[TBL] [Abstract][Full Text] [Related]
27. Proteasome-dependent processing of topoisomerase I-DNA adducts into DNA double strand breaks at arrested replication forks.
Lin CP; Ban Y; Lyu YL; Liu LF
J Biol Chem; 2009 Oct; 284(41):28084-28092. PubMed ID: 19666469
[TBL] [Abstract][Full Text] [Related]
28. DNA Damage-Response Pathway Heterogeneity of Human Lung Cancer A549 and H1299 Cells Determines Sensitivity to 8-Chloro-Adenosine.
Yang SY; Li Y; An GS; Ni JH; Jia HT; Li SY
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29843366
[TBL] [Abstract][Full Text] [Related]
29. TDP1-independent pathways in the process and repair of TOP1-induced DNA damage.
Zhang H; Xiong Y; Su D; Wang C; Srivastava M; Tang M; Feng X; Huang M; Chen Z; Chen J
Nat Commun; 2022 Jul; 13(1):4240. PubMed ID: 35869071
[TBL] [Abstract][Full Text] [Related]
30. Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.
Das SK; Ghosh A; Paul Chowdhuri S; Halder N; Rehman I; Sengupta S; Sahoo KC; Rath H; Das BB
J Med Chem; 2018 Feb; 61(3):804-817. PubMed ID: 29290109
[TBL] [Abstract][Full Text] [Related]
31. Processing of topoisomerase I cleavable complexes into DNA damage by transcription.
Wu J; Liu LF
Nucleic Acids Res; 1997 Nov; 25(21):4181-6. PubMed ID: 9336444
[TBL] [Abstract][Full Text] [Related]
32. Mus81-mediated DNA cleavage resolves replication forks stalled by topoisomerase I-DNA complexes.
Regairaz M; Zhang YW; Fu H; Agama KK; Tata N; Agrawal S; Aladjem MI; Pommier Y
J Cell Biol; 2011 Nov; 195(5):739-49. PubMed ID: 22123861
[TBL] [Abstract][Full Text] [Related]
33. PARP-1-dependent RND1 transcription induced by topoisomerase I cleavage complexes confers cellular resistance to camptothecin.
Mouly L; Mamouni K; Gence R; Cristini A; Cherier J; Castinel A; Legrand M; Favre G; Sordet O; Monferran S
Cell Death Dis; 2018 Sep; 9(9):931. PubMed ID: 30209297
[TBL] [Abstract][Full Text] [Related]
34. Dynamic Effects of Topoisomerase I Inhibition on R-Loops and Short Transcripts at Active Promoters.
Marinello J; Bertoncini S; Aloisi I; Cristini A; Malagoli Tagliazucchi G; Forcato M; Sordet O; Capranico G
PLoS One; 2016; 11(1):e0147053. PubMed ID: 26784695
[TBL] [Abstract][Full Text] [Related]
35. Cullin 3 promotes proteasomal degradation of the topoisomerase I-DNA covalent complex.
Zhang HF; Tomida A; Koshimizu R; Ogiso Y; Lei S; Tsuruo T
Cancer Res; 2004 Feb; 64(3):1114-21. PubMed ID: 14871846
[TBL] [Abstract][Full Text] [Related]
36. PRMT5-mediated arginine methylation of TDP1 for the repair of topoisomerase I covalent complexes.
Rehman I; Basu SM; Das SK; Bhattacharjee S; Ghosh A; Pommier Y; Das BB
Nucleic Acids Res; 2018 Jun; 46(11):5601-5617. PubMed ID: 29718323
[TBL] [Abstract][Full Text] [Related]
37. Camptothecin-induced downregulation of MLL5 contributes to the activation of tumor suppressor p53.
Cheng F; Liu J; Teh C; Chong SW; Korzh V; Jiang YJ; Deng LW
Oncogene; 2011 Aug; 30(33):3599-611. PubMed ID: 21423215
[TBL] [Abstract][Full Text] [Related]
38. A ubiquitin-proteasome pathway for the repair of topoisomerase I-DNA covalent complexes.
Lin CP; Ban Y; Lyu YL; Desai SD; Liu LF
J Biol Chem; 2008 Jul; 283(30):21074-83. PubMed ID: 18515798
[TBL] [Abstract][Full Text] [Related]
39. The role of single strand break repair pathways in cellular responses to camptothecin induced DNA damage.
Mei C; Lei L; Tan LM; Xu XJ; He BM; Luo C; Yin JY; Li X; Zhang W; Zhou HH; Liu ZQ
Biomed Pharmacother; 2020 May; 125():109875. PubMed ID: 32036211
[TBL] [Abstract][Full Text] [Related]
40. Topoisomerase IIβ deficiency enhances camptothecin-induced apoptosis.
Lin RK; Ho CW; Liu LF; Lyu YL
J Biol Chem; 2013 Mar; 288(10):7182-92. PubMed ID: 23344961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
